Io Biotech Stock Investor Sentiment
| IOBT Stock | USD 0.88 0.01 1.12% |
Slightly above 91 percent of IO Biotech's private investors are aggressively looking to sell. The analysis of the overall investor sentiment regarding IO Biotech suggests that a very large number of traders are panicking. IO Biotech's investing sentiment can be driven by a variety of factors including economic data, IO Biotech's earnings reports, geopolitical events, and overall market trends.
Comfort Level 9
Terrified
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use IO Biotech's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward IO Biotech.
News SentimentBearish | Hype SentimentBearish | Insider SentimentDisposing |
IOBT Historical Sentiment
Although IO Biotech's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding IOBT, such as negative comments on social media and news outlets, may cause fear in the market and push IO Biotech's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of IOBT.
IOBT |
IO Biotech Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards IO Biotech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about IO Biotech that are available to investors today. That information is available publicly through IOBT media outlets and privately through word of mouth or via IOBT internal channels. However, regardless of the origin, that massive amount of IOBT data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of IO Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of IO Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to IO Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive IO Biotech alpha.
IO Biotech Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | IO Biotech secures up to 57.5 million in debt financing from the European Investment Bank | 12/20/2024 |
2 | IO Biotech Adopts Amended and Restated Bylaws | 12/23/2024 |
3 | Insider Trading | 01/10/2025 |
4 | Acquisition by Hunter Heidi of 64238 shares of IO Biotech at 1.83 subject to Rule 16b-3 | 01/21/2025 |
5 | Jefferies maintains IO Biotech Buy rating, 8 target on PFS hopes - Investing.com | 01/27/2025 |
6 | IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candid... | 02/04/2025 |
7 | IO Biotech stock retains Buy rating, 12 target at H.C. Wainwright - Investing.com India | 03/05/2025 |
8 | HC Wainwright Reiterates Buy Rating for IO Biotech - Defense World | 03/07/2025 |
9 | Acquisition by Novo Holdings As of 2469135 shares of IO Biotech at 2.025 subject to Rule 16b-3 | 03/12/2025 |
10 | Acquisition by Nielsen Jack of 2365545 shares of IO Biotech subject to Rule 16b-3 | 03/14/2025 |
Additional Tools for IOBT Stock Analysis
When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.